ArticleEmergency radiology2025
Improving the management of acute subdural hematomas; identifying characteristics associated with acute subdural hematoma size and expansion.
Article in Emergency radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe incidence of subdural hematomas (SDHs) is increasing due to the aging population, frequent use of anticoagulants/antiplatelets, and fall-related trauma. While some acute SDHs remain stable and require no intervention, others expand, necessitating neurosurgical management. Our study objective was to better identify predictors of acute SDH enlargement to guide clinical management.
methodsThis retrospective study analyzed 32,401 noncontrast CT brain scans over six years. We identified 262 patients with acute SDHs and evaluated demographic, clinical, and radiologic factors associated with hematoma enlargement and the need for surgical intervention. Statistical analyses, including univariate analyses, logistic regression and receiver operating characteristic curves, were performed to determine predictors of SDH growth and surgery.
resultsSDH enlargement occurred in 58/232 (25%) of patients with follow-up imaging. Larger initial SDH size, concurrent subarachnoid hemorrhage, hypertension, convexity location, and midline shift were significantly associated with hematoma expansion (p < 0.05). No patient with an initial SDH ≤ 3 mm required surgery initially or in follow-up, although 8/72 (11.1%) enlarged (maximum width 10 mm). An 8.5-mm initial SDH size threshold best predicted the need for surgical intervention (AUC 0.81).
conclusionsInitial SDH size, hypertension, SAH, initial midline shift, and convexity location are key predictors of hematoma expansion. Although patients' with SDHs ≤ 3 mm rarely expanded, they never required surgery. A prospective study to determine a more judicious use of hospital-based resources, especially for those patients with initial SDH size > 3 mm who have risk factors for expansion, would be an important step in the management of SDHs.
Indexed as
Identifiers
40817177What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.